| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8349777 | Pharmacological Reports | 2018 | 18 Pages |
Abstract
It was found that the FXR antagonist, compound-T0 exacerbated dyslipidemia in mice because it enhanced intestinal lipid absorption via acceleration of bile acid excretion.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Yuichiro Amano, Hiroko Yamakawa, Kazuko Yonemori, Mitsuyuki Shimada, Ryuichi Tozawa,